Experiences of serious depression and serious anxiety among clients receiving injectable opioid agonist treatment (iOAT)

Original research
par
Magel, Tianna et al

Date de publication

2023

Géographie

Canada

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Oui

Évalué par des pairs

Yes

L’objectif

This study aims to provide evidence of factors that impact participant reported serious depression and serious anxiety among individuals receiving injectable opioid agonist treatment (iOAT).

Constatations/points à retenir

Depression and anxiety are highly prevalent among clients receiving iOAT. While both disorders share several factors, there are distinct characteristics associated with each outcome. These include poorer physical health, experiences of abuse, illicit substance use, and social problems. Understanding factors that influence depression and anxiety in iOAT can assist providers in supporting iOAT clients' mental health and developing individualized care plans.

La conception ou méthodologie de recherche

Data from an 18-month longitudinal retrospective cohort of individuals receiving iOAT (n=131).

Mots clés

About PWUD
Mental health